INSIGHTS ON DRUG DEVELOPMENT

• Understand Fluorescence And How It Enhances Scientific Exploration

  Deepen your understanding of fluorescence for research, and gain valuable insight into how to select appropriate fluorophores and fluorescent proteins for your experiments.

• T3P – A Green Solution For Peptide Coupling, Water Removal Reactions

  The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.

• Calcium Carbonate As TiO2 Alternative In Coating

  Explore how calcium carbonate can replace titanium dioxide in tablet coating, as well as learn formulation strategies and review color performance data to support high-quality finishes in applications.

• Customized Release Through Dispersed Dosage Formats

  Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.

• Leveraging Optimized Transient Expression For Material Generation And Early Stage Insight

  7/23/2024

  By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

• Creating A Shigella Infection Model Using Organs-On-Chips

  4/9/2024

  Learn how researchers have utilized Organs-on-Chips technology to test the infectivity of Shigella through several experimental approaches.

• Cell Culture Media Filtration: Evaluating Cell Culture Performance

  10/23/2025

  Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.

• The Role Of A Consulting Firm In The IND Process

  6/10/2025

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

• Assessing Production And Stability Of Antibody Drug Conjugate Platforms

  9/24/2025

  ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.